Literature DB >> 22358437

Molecular biology of Philadelphia chromosome in chronic granulocytic leukaemia and acute lymphoblastic leukaemia.

S Eridani1, L M Wiedemann, L C Chan, R G Dalton, K K Karhi.   

Abstract

In classical t(9;22) translocation, as observed in chronic granulocytic leukemia (CGL), a hybrid DNA unit is produced, including a rearranged PHL gene, previously known as bcr (breakpoint cluster region) plus the translocated c-abl gene from chromosome 9: a hybrid bcr-abl protein, p210 is formed, with increased tyrosine kinase activity. Such DNA rearrangement, with a p210 protein synthesis, is also found in cases of Philadelphia-positive acute lymphoblastic leukemia (ALL), but in apparently similar cases the bcr gene is not rearranged, and a novel p190 abl-related protein can be found; c-abl rearrangement has also been observed.It is thus established that correlations between cytogenetic and molecular events can be found in CGL and ALL, as in other haemopoietic malignancies: translocation and possible rearrangement of the c-abl oncogene seem of particular importance in this case.

Entities:  

Year:  1987        PMID: 22358437     DOI: 10.1007/BF00351119

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  17 in total

1.  Rearrangement in the breakpoint cluster region and the clinical course in Philadelphia-negative chronic myelogenous leukemia.

Authors:  R Kurzrock; M B Blick; M Talpaz; W S Velasquez; J M Trujillo; N M Kouttab; W S Kloetzer; R B Arlinghaus; J U Gutterman
Journal:  Ann Intern Med       Date:  1986-11       Impact factor: 25.391

2.  Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL.

Authors:  S S Clark; J McLaughlin; W M Crist; R Champlin; O N Witte
Journal:  Science       Date:  1987-01-02       Impact factor: 47.728

3.  The Ph1 chromosome in childhood leukaemia.

Authors:  J M Chessells; G Janossy; S D Lawler; L M Secker Walker
Journal:  Br J Haematol       Date:  1979-01       Impact factor: 6.998

4.  The minimum transforming region of v-abl is the segment encoding protein-tyrosine kinase.

Authors:  R Prywes; J G Foulkes; D Baltimore
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

5.  Evidence for clonal development of childhood acute lymphoblastic leukemia.

Authors:  L W Dow; P Martin; J Moohr; M Greenberg; L G Macdougall; V Najfeld; P J Fialkow
Journal:  Blood       Date:  1985-10       Impact factor: 22.113

6.  An 8-kilobase abl RNA transcript in chronic myelogenous leukemia.

Authors:  R P Gale; E Canaani
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

7.  Heterogeneity of chromosome 22 breakpoint in Philadelphia-positive (Ph+) acute lymphocytic leukemia.

Authors:  J Erikson; C A Griffin; A ar-Rushdi; M Valtieri; J Hoxie; J Finan; B S Emanuel; G Rovera; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

8.  A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia.

Authors:  A de Klein; A G van Kessel; G Grosveld; C R Bartram; A Hagemeijer; D Bootsma; N K Spurr; N Heisterkamp; J Groffen; J R Stephenson
Journal:  Nature       Date:  1982-12-23       Impact factor: 49.962

9.  bcr rearrangement and translocation of the c-abl oncogene in Philadelphia positive acute lymphoblastic leukemia.

Authors:  A De Klein; A Hagemeijer; C R Bartram; R Houwen; L Hoefsloot; F Carbonell; L Chan; M Barnett; M Greaves; E Kleihauer
Journal:  Blood       Date:  1986-12       Impact factor: 22.113

10.  Localization of the c-ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukaemia.

Authors:  N Heisterkamp; J R Stephenson; J Groffen; P F Hansen; A de Klein; C R Bartram; G Grosveld
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.